期刊文献+

综合护理干预在老年晚期肺癌合并深静脉血栓患者中的效果 被引量:7

Effect ofComprehensive Nursing Intervention on Elderly Patients with Advanced Lung Cancer Complicated with Deep Vein Thrombosis
下载PDF
导出
摘要 目的探究综合护理干预在老年晚期肺癌合并深静脉血栓患者中的应用效果。方法2017年8月至2018年12月来我院进行治疗的肺癌合并深静脉血栓形成(DVT)患者86例,采用随机数表法将86例患者分为观察组(43例)和对照组(43例)。对照组和观察组采用常规的化疗药物治疗以抗凝药物治疗,观察组在此基础之上采用综合干预。观察和分析综合干预治疗有效率、及对患者焦虑、抑郁、生活质量以及护理满意度的影响。结果观察组治疗有效率为74.4%高于对照组的67.1%,但差异无统计学意义;治疗前,观察组患者焦虑、抑郁、生活质量得分与观察组焦虑、抑郁、生活质量得分无统计学差异(P>0.05);经过治疗,观察组焦虑、抑郁评分明显低于对照组,而生活治疗得分高于对照组(P<0.05)。察组患者护理满意度86.0%高于对照组65.1%(P<0.05)。结论综合干预在老年晚期肺癌合并DVT患者中显著改善患者不良情绪,提生生活质量,提高护理满意度。
作者 曾凡 胡娟 ZENG Fan;HU Juan(Tongji Hospital affiliated to Tongji Medical College,Huazhong University of Medicine,Wuhan,430030,China)
出处 《血栓与止血学》 2019年第5期848-849,共2页 Chinese Journal of Thrombosis and Hemostasis
  • 相关文献

参考文献6

二级参考文献82

  • 1郑磊磊,王也玲,李惠春.医院焦虑抑郁量表在综合性医院中的应用[J].上海精神医学,2003,15(5):264-266. 被引量:249
  • 2孙敏莉,张柏根.急性下肢深静脉血栓形成治疗的选择及评价[J].中国实用外科杂志,2006,26(10):756-758. 被引量:31
  • 3Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med, 2004, 350(21): 2129-2139. 被引量:1
  • 4Melosky B. Treatment algorithms for patients with metastatic non- small cell, non-squamous lung cancer[J]. Front Oncol, 2014, 4: 256. 被引量:1
  • 5Ye T, Pan -, Wang R, et al. Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old[J]. J Thorac Dis, 2014, 6(10): 1396-1402. 被引量:1
  • 6Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med, 2002, 346(2): 92-98. 被引量:1
  • 7Jiang J, Liang X, Zhou X, et al. Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naive advanced non-small-cell lung cancer in the era of third-generation agents[J]. J Cancer Res Clin Oncol, 2013, 139(1): 25-38. 被引量:1
  • 8Scagliotti GV, Pafikh P, von Pawel J, et al. Phase 111 study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J]. J Clin Oncol, 2008, 26(21): 3543-3551. 被引量:1
  • 9Cobo M, Isla D, Massuti B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase HI trial in non-small-ceU lung cancer[J]. J Clin Oncol, 2007, 25(19): 2747-2754. 被引量:1
  • 10Bepler G, Williams C, Schell MJ, et al. Randomized international phase II1 trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non- small-cell lung cancer[J]. J Clin Oncol, 2013, 31(19): 2404-2412. 被引量:1

共引文献345

同被引文献49

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部